Austrian Breast & Colorectal Cancer Study Group

Science from the heart of Europe

Empfehlungen zu Diagnostik und multimodaler Primärtherapie des Rektumkarzinoms 2004

ABCSG, ACO/ASSO, ÖGC, ÖGHO, ÖGP, ÖGRO, ÖRG

Wiener Klinische Wochenschrift 2004.: 10.1007/s00508-005-0323-1

https://www.springermedizin.de/empfehlungen-zu-diagnostik-und-multimodaler-primaertherapie-des-/8563870

---

Amenorrhoea, aromatase inhibitors, tamoxifen or a combination in premenopausal women.

Jakesz R

European Journal of Cancer

https://cyberleninka.org/article/n/275469

---

Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer.

Schoppmann SF, Bayer G, Aumayr K, Taucher S, Geleff S, Rudas M, Kubista E, Hausmaninger H, Samonigg H, Gnant M, Jakesz R, Horvat R

Annals of Surgery

https://www.ncbi.nlm.nih.gov/pubmed/15273556

---

The impact of progesterone receptor in prediction of complete pathological response to preoperative chemotherapy in primary breast cancer patients.

Taucher S, Rudas M, Gnant M, Dubsky P, Sporn E, Roka S, Bachleitner T, Fitzal F, Kandioler D, Wenzel C, Steger G, Draxler W, Mittlböck M, Jakesz R

European Surgery

https://link.springer.com/article/10.1007/s10353-004-0028-0

Incidence of liver metastases in patients receiving adjuvant chemotherapy after lymph node positive primary colon cancer

Gruenberger T, Schwanzer E, Samonigg H, Hausmaninger H, Jakesz R

Journal of Gastrointestinal Surgery

---

Pelvic radiological imaging: a surgeon’s perspective

Herbst F

European Journal of Radiology

https://www.ncbi.nlm.nih.gov/pubmed/12880994

---

Significant increase in breast conservation in 16 years of trials conducted by the Austrian Breast & Colorectal Cancer Study Group (ABCSG)

Jakesz R, Samonigg H, Gnant M, Kubista E, Depisch D, Kolb R, Mlineritsch B, Mischinger HJ, Menzel RC, Steindorfer P, Kwasny W, Tausch C, Stierer M, Taucher S, Seifert M, Hausmaninger H

Annals of Surgery

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1514470/

---

In reply to: Paradigm shift in adjuvant treatment of receptor positive premenopausal breast cancer patients? Not yet.

Jakesz R

Journal of Clinical Oncology

---

Randomised trial: One cycle of anthracycline-containing adjuvant chemotherapy compared with six cycles of CMF treatment in node-positive, hormone receptor negative breast cancer patients

Ploner F, Jakesz R, Hausmaninger H, Kolb R, Stierer M, Fridrik M, Steindorfer P, Gnant M, Haider K, Mlineritsch B, Tschurtschenthaler G, Steger G, Seifert M, Kubista E, Samonigg H

Onkologie

https://www.ncbi.nlm.nih.gov/pubmed/12771518

---

High p27 Kip1 expression predicts superior relapse-free and overall survival for premenopausal women with early-stage breast cancer receiving adjuvant treatment with tamoxifen plus goserelin

Pohl G, Rudas M, Dietze O, Lax S, Markis E, Pirker R, Zielinski C, Hausmaninger H, Kubista E, Samonigg H, Jakesz R, Filiptis M

Journal of Clinical Oncology

https://www.ncbi.nlm.nih.gov/pubmed/14512390

---

Randomized trial of tamoxifen vs tamoxifen plus aminoglutethimide as adjuvant treatment in postmenopausal breast cancer patients with hormone receptor-positive disease: Austrian Breast and Colorectal Cancer Study Group Trial 6.

Schmid M, Jakesz R, Samonigg H, Kubista E, Gnant M, Menzel C, Seifert M, Haider K, Taucher S, Mlineritsch B, Steindorfer P, Kwasny W, Stierer M, Tausch C, Fridrik M, Wette V, Steger G, Hausmaninger H

Journal of Clinical Oncology

https://www.ncbi.nlm.nih.gov/pubmed/12637461

---

Dendritic Cell-Based Vaccination in Solid Cancer

Stift A, Dubsky P, Bachleitner-Hofmann T, Schueller G, Zontsich T, Benkoe T, Radelbauer K, Brostjan C, Jakesz R, Gnant M

Journal of Clinical Oncology

https://www.ncbi.nlm.nih.gov/pubmed/12506182

---

Sequential steroid hormone receptor measurements in primary breast cancer with and without intervening primary chemotherapy

Taucher S, Rudas M, Gnant M, Thomanek K, Dubsky P, Roka S, Bachleitner T, Kandioler D, Wenzel C, Steger G, Mittlböck M, Jakesz R

Endocrine-Related Cancer

https://www.ncbi.nlm.nih.gov/pubmed/12653672

---

Preventive mastectomy in patients at breast cancer risk due to genetic alterations in the BRCA1 and BRCA2 gene

Taucher S, Gnant M, Jakesz R

Langenbecks Archive of Surgery

https://www.ncbi.nlm.nih.gov/pubmed/12690474

---

Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer

Schoppmann SF, Schindl M, Bayer G, Aumayr K, Dienes J, Horvat R, Rudas M, Gnant M, Jakesz R, Birner P

Wiley-Liss DOI 10.1002/ijc.11009

https://www.ncbi.nlm.nih.gov/pubmed/12640673

---

Impact of pretreatment thromboyctosis on survival in primary breast cancer

Taucher S, Salat A, Gnant M, Kwasny W, Mlineritsch B, Menzel RC, Schmid M, Smola MG, Stierer M, Tausch C, Galid A, Steger G, Jakesz R

Thrombosis & Haemostasis

https://www.ncbi.nlm.nih.gov/pubmed/12783124

---

High p27Kip1 expression predicts superior relapse-free and overall survival for premenopausal women with early-stage breast cancer receiving adjuvant treatment with tamoxifen plus goserelin

Pohl G, Rudas M, Dietze O, Lax S, Markis E, Pirker R, Zielinski CC, Hausmaninger H, Kubista E, Samonigg H, Jakesz R, Filipits M.

J Clin Oncol 21, 3594-3600, 2003

Identification of Sentinel Lymph Nodes in Breast Cancer by Lymphoscintingraphy and Gamma Probe Guidance: Dependence on Route of Injection and Tumour Location

Gallowitsch JH, Konstantiniuk P, Jörg L, Urbania A, Kugler F, Peschina W, Hatzl-Griesenhofer M, Zettinig G

European Surgery

https://onlinelibrary.wiley.com/doi/abs/10.1046/j.1563-2563.2002.02072.x

---

The importance of sentinel node biopsy in breast surgery

Haid A, Schrenk P, Roka S, Tausch C, Pichler-Gebhard B, Rudas M, Zimmermann G

European Surgery

https://onlinelibrary.wiley.com/doi/abs/10.1046/j.1563-2563.2002.02065.x

---

Chemotherapy versus hormonal adjuvant treatment in premenopausal patients with breast cancer

Jakesz R, Hausmaninger H, Samonigg H

European Journal of Cancer

https://www.ncbi.nlm.nih.gov/pubmed/11818196

---

Randomized adjuvant trial of tamoxifen and goserelin versus cyclophospamide, methotrexate, and fluorouracil: Evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer

Jakesz R, Hausmaninger H, Kubista E, Gnant M, Menzel C, Bauernhofer T, Seifert M, Haider K, Mlineritsch B, Steindorfer P, Kwasny W, Fridrik M, Steger G, Wette V, Samonigg H

Journal of Clinical Oncology

https://www.ncbi.nlm.nih.gov/pubmed/12488405

---

Standards in der Mamma-Ca-Therapie

Jakesz R

Wiener Klinische Wochenschrift

---

Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer

Schindl M, Schoppmann F, Samonigg H, Hausmaninger H, Kwasny W, Gnant M, Jakesz R, Kubista E, Birner P, Oberhuber G

Clinical Cancer Research

https://www.researchgate.net/publication/11313017.. Breast_Cancer

---

Survival of women with breast cancer in Austria by age, stage and period of diagnosis

Vutuc Chr, Waldhoer T, Klimot J, Haidinger G, Jakesz R, Kubist E, Zielinski C

Wiener Klinische Wochenschrift

https://www.ncbi.nlm.nih.gov/pubmed/12422577

Evaluation of the United States Food and Drug Administration approved Scoring and Test System of HER-2 Protein Expression in Breast Cancer

Birner P, Oberhuber G, Stani J, Reithofer C, Samonigg H, Hausmaninger H, Kubista E, Kwasny W, Kandioler-Eckersberger D, Gnant M, Jakesz R

Clinical Cancer Research

https://www.ncbi.nlm.nih.gov/pubmed/11410505

---

Prognostic relevance of three histological grading methods in breast cancer

Latinovic L, Heinze G, Birner P, Samonigg H, Hausmaninger H, Kubista E, Kwasny W, Gnant M, Jakesz R, Oberhuber G

International Journal of Oncology

https://www.ncbi.nlm.nih.gov/pubmed/11713599